Ixazomib enhances parathyroid hormone–induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor

por Yang, Yanmei, Lei, Hong, Qiang, Ya-wei, Wang, Bin
Publicado 2017

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma

por Qiang, Ya-Wei, Ye, Shiqiao, Huang, Yuhua, Chen, Yu, Van Rhee, Frits, Epstein, Joshua, Walker, Brian A., Morgan, Gareth J., Davies, Faith E.
Publicado 2018

Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma

por Hu, Bo, Chen, Yu, Usmani, Saad Z., Ye, Shiqiao, Qiang, Wei, Papanikolaou, Xenofon, Heuck, Christoph J., Yaccoby, Shmuel, Williams, Bart O., Van Rhee, Frits, Barlogie, Bart, Epstein, Joshua, Qiang, Ya-Wei
Publicado 2013

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

por Walker, Brian A, Wardell, Christopher P, Murison, Alex, Boyle, Eileen M, Begum, Dil B, Dahir, Nasrin M, Proszek, Paula Z, Melchor, Lorenzo, Pawlyn, Charlotte, Kaiser, Martin F, Johnson, David C, Qiang, Ya-Wei, Jones, John R, Cairns, David A, Gregory, Walter M, Owen, Roger G, Cook, Gordon, Drayson, Mark T, Jackson, Graham H, Davies, Faith E, Morgan, Gareth J
Publicado 2015